Cite
HARVARD Citation
Thomas, A. et al. (n.d.). Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial. Lancet oncology. 16 (2), pp. 177-186. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Thomas, A. et al. (n.d.). Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial. Lancet oncology. 16 (2), pp. 177-186. [Online].